{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:40:39Z","timestamp":1768286439952,"version":"3.49.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.maturitas.2014.05.024","type":"journal-article","created":{"date-parts":[[2014,6,6]],"date-time":"2014-06-06T06:30:41Z","timestamp":1402036241000},"page":"341-343","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Peyronie's disease: Review and recent advances"],"prefix":"10.1016","volume":"78","author":[{"given":"Joshua P.","family":"Langston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"Culley C.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.maturitas.2014.05.024_bib0005","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1159\/000049830","article-title":"Peyronie's disease: prevalence and association with cigarette smoking. A multicenter population-based study in men aged 50\u201369 years","volume":"40","author":"La Pera","year":"2001","journal-title":"Eur Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0010","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1097\/01.ju.0000127744.18878.f1","article-title":"Subjective and objective analysis of the prevalence of Peyronie's disease in a population of men presenting for prostate cancer screening","volume":"171","author":"Mulhall","year":"2004","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.maturitas.2014.05.024_bib0015","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ijir.3901518","article-title":"The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction","volume":"19","author":"Arafa","year":"2007","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0020","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1046\/j.1464-4096.2001.02436.x","article-title":"The prevalence of Peyronie's disease: results of a large survey","volume":"88","author":"Schwarzer","year":"2001","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.maturitas.2014.05.024_bib0025","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/ncpuro0201","article-title":"Mechanisms of disease: new insights into the cellular and molecular pathology of Peyronie's disease","volume":"2","author":"Gonzalez-Cadavid","year":"2005","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0030","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0022-5347(17)39746-X","article-title":"The natural history of Peyronie's disease","volume":"144","author":"Gelbard","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0035","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(06)00270-9","article-title":"An analysis of the natural history of Peyronie's disease","volume":"175","author":"Mulhall","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0040","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0022-5347(05)67525-8","article-title":"Evidence-based assessment of long-term results in plaque incision and vein grafting for Peyronie's disease","volume":"163","author":"Montorsi","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0045","first-page":"62","article-title":"Francois Gigot de la Peyronie (1678\u20131747)","volume":"19","author":"Carson","year":"1981","journal-title":"Invest Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0050","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0055","doi-asserted-by":"crossref","DOI":"10.1111\/bju.12634","article-title":"Minimally invasive treatment of Peyronie's disease: evidence-based progress","author":"Jordan","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0060","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0022-5347(01)64224-1","article-title":"Treatment of Peyronie's disease with intralesional verapamil injection","volume":"158","author":"Levine","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0065","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie's disease","volume":"69","author":"Bennett","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0070","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo-controlled, parallel study to assess","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0080","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of clinical efficacy and safety of collagenase clostridium histolyticum in patients with Peyronie's disease","volume":"187","author":"Gelbard","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0085","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.urology.2007.11.065","article-title":"Subjective patient-reported experiences after surgery for Peyronie's disease: corporeal plication versus plaque incision with vein graft","volume":"71","author":"Kim","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0090","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/bju.12565","article-title":"Outcomes of surgical treatment of Peyronie's disease","volume":"113","author":"Carson","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0095","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1743-6109.2005.20113.x","article-title":"A surgical algorithm for men with combined Peyronie's disease and erectile dysfunction: functional and satisfaction outcomes","volume":"2","author":"Mulhall","year":"2005","journal-title":"J Sex Med"},{"key":"10.1016\/j.maturitas.2014.05.024_bib0100","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/j.1743-6109.2008.00895.x","article-title":"The chronology of depression and distress in men with Peyronie's disease","volume":"5","author":"Nelson","year":"2008","journal-title":"J Sex Med"}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512214001935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:00:34Z","timestamp":1759914034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512214001935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0378512214001935"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.024","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peyronie's disease: Review and recent advances","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2014.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}